1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Regulatory Fitness in Rare Disease Clinical Trials Workshop (Day 2)"}],["$","meta","1",{"name":"description","content":"This is a workshop jointly sponsored by the NIH National Center for Advancing Translational Sciences (NCATS) and the U.S. FDA Center for Drug Evaluation and Research (CDER) to explore Regulatory Fitness in Rare Disease Clinical Trials. Topics include: adequate and well-controlled trials, core principles for clinical trials, nuts and bolts of investigational new drug (IND) applications, additional pathways to interact with FDA CDER, and case studies.\n\n\n\n

\nTo see when specific talks begin, view the timestamps: https://www.fda.gov/media/169131/download\n\n\n\n

\n\nFor more information go to https://www.fda.gov/drugs/news-events-human-drugs/fda-cder-nih-ncats-regulatory-fitness-rare-disease-clinical-trials-workshop-05162022\n"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Regulatory Fitness in Rare Disease Clinical Trials Workshop (Day 2)"}],["$","meta","4",{"property":"og:description","content":"This is a workshop jointly sponsored by the NIH National Center for Advancing Translational Sciences (NCATS) and the U.S. FDA Center for Drug Evaluation and Research (CDER) to explore Regulatory Fitness in Rare Disease Clinical Trials. Topics include: adequate and well-controlled trials, core principles for clinical trials, nuts and bolts of investigational new drug (IND) applications, additional pathways to interact with FDA CDER, and case studies.\n\n\n\n

\nTo see when specific talks begin, view the timestamps: https://www.fda.gov/media/169131/download\n\n\n\n

\n\nFor more information go to https://www.fda.gov/drugs/news-events-human-drugs/fda-cder-nih-ncats-regulatory-fitness-rare-disease-clinical-trials-workshop-05162022\n"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/c68658d5-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/334e39e1-4ae3-431c-aa58-6cb1e97e9b87.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Regulatory Fitness in Rare Disease Clinical Trials Workshop (Day 2)"}],["$","meta","11",{"name":"twitter:description","content":"This is a workshop jointly sponsored by the NIH National Center for Advancing Translational Sciences (NCATS) and the U.S. FDA Center for Drug Evaluation and Research (CDER) to explore Regulatory Fitness in Rare Disease Clinical Trials. Topics include: adequate and well-controlled trials, core principles for clinical trials, nuts and bolts of investigational new drug (IND) applications, additional pathways to interact with FDA CDER, and case studies.\n\n\n\n

\nTo see when specific talks begin, view the timestamps: https://www.fda.gov/media/169131/download\n\n\n\n

\n\nFor more information go to https://www.fda.gov/drugs/news-events-human-drugs/fda-cder-nih-ncats-regulatory-fitness-rare-disease-clinical-trials-workshop-05162022\n"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}